Cargando…

Severely impaired microvascular reactivity in diabetic patients with an acute coronary syndrome

BACKGROUND: Microvascular function is impaired in patients with stable coronary artery disease. The aim was to study microvascular function in patients with diabetes and acute coronary syndrome (ACS). METHODS: Microvascular function was evaluated in 83 patients by laser Doppler fluxmetry (LDF) [PU;...

Descripción completa

Detalles Bibliográficos
Autores principales: Östlund Papadogeorgos, Nikolaos, Jörneskog, Gun, Bengtsson, Mattias, Kahan, Thomas, Kalani, Majid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4837627/
https://www.ncbi.nlm.nih.gov/pubmed/27095564
http://dx.doi.org/10.1186/s12933-016-0385-6
_version_ 1782427887669870592
author Östlund Papadogeorgos, Nikolaos
Jörneskog, Gun
Bengtsson, Mattias
Kahan, Thomas
Kalani, Majid
author_facet Östlund Papadogeorgos, Nikolaos
Jörneskog, Gun
Bengtsson, Mattias
Kahan, Thomas
Kalani, Majid
author_sort Östlund Papadogeorgos, Nikolaos
collection PubMed
description BACKGROUND: Microvascular function is impaired in patients with stable coronary artery disease. The aim was to study microvascular function in patients with diabetes and acute coronary syndrome (ACS). METHODS: Microvascular function was evaluated in 83 patients by laser Doppler fluxmetry (LDF) [PU; perfusion unit, median (interquartile range)] measuring resting LDF and peak LDF following a six min heating of the skin to 44 °C at the foot, respectively. All patients with ACS and without previously known diabetes underwent oral glucose tolerance test. Thirty-nine patients with type 2 diabetes mellitus free from coronary artery disease served as controls. RESULTS: Peak LDF was significantly (P = 0.03) lower in patients with ACS and diabetes (n = 22; 72 (52)) and diabetes without coronary artery disease (n = 39; 69 (51)) as compared to patients with ACS without diabetes (n = 46; 97 (60)), and patients without ACS (n = 15; 140 (121)), respectively. Patients with ACS (n = 68) had significantly (P = 0.04) lower peak LDF (92 (49)) as compared to patients without ACS (n = 15) (140 (121)). CONCLUSION: Microvascular reactivity is severely impaired in patients with diabetes and ACS. Diabetes has a major influence on microvascular function in patients with coronary artery disease.
format Online
Article
Text
id pubmed-4837627
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-48376272016-04-21 Severely impaired microvascular reactivity in diabetic patients with an acute coronary syndrome Östlund Papadogeorgos, Nikolaos Jörneskog, Gun Bengtsson, Mattias Kahan, Thomas Kalani, Majid Cardiovasc Diabetol Original Investigation BACKGROUND: Microvascular function is impaired in patients with stable coronary artery disease. The aim was to study microvascular function in patients with diabetes and acute coronary syndrome (ACS). METHODS: Microvascular function was evaluated in 83 patients by laser Doppler fluxmetry (LDF) [PU; perfusion unit, median (interquartile range)] measuring resting LDF and peak LDF following a six min heating of the skin to 44 °C at the foot, respectively. All patients with ACS and without previously known diabetes underwent oral glucose tolerance test. Thirty-nine patients with type 2 diabetes mellitus free from coronary artery disease served as controls. RESULTS: Peak LDF was significantly (P = 0.03) lower in patients with ACS and diabetes (n = 22; 72 (52)) and diabetes without coronary artery disease (n = 39; 69 (51)) as compared to patients with ACS without diabetes (n = 46; 97 (60)), and patients without ACS (n = 15; 140 (121)), respectively. Patients with ACS (n = 68) had significantly (P = 0.04) lower peak LDF (92 (49)) as compared to patients without ACS (n = 15) (140 (121)). CONCLUSION: Microvascular reactivity is severely impaired in patients with diabetes and ACS. Diabetes has a major influence on microvascular function in patients with coronary artery disease. BioMed Central 2016-04-20 /pmc/articles/PMC4837627/ /pubmed/27095564 http://dx.doi.org/10.1186/s12933-016-0385-6 Text en © Östlund Papadogeorgos et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Original Investigation
Östlund Papadogeorgos, Nikolaos
Jörneskog, Gun
Bengtsson, Mattias
Kahan, Thomas
Kalani, Majid
Severely impaired microvascular reactivity in diabetic patients with an acute coronary syndrome
title Severely impaired microvascular reactivity in diabetic patients with an acute coronary syndrome
title_full Severely impaired microvascular reactivity in diabetic patients with an acute coronary syndrome
title_fullStr Severely impaired microvascular reactivity in diabetic patients with an acute coronary syndrome
title_full_unstemmed Severely impaired microvascular reactivity in diabetic patients with an acute coronary syndrome
title_short Severely impaired microvascular reactivity in diabetic patients with an acute coronary syndrome
title_sort severely impaired microvascular reactivity in diabetic patients with an acute coronary syndrome
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4837627/
https://www.ncbi.nlm.nih.gov/pubmed/27095564
http://dx.doi.org/10.1186/s12933-016-0385-6
work_keys_str_mv AT ostlundpapadogeorgosnikolaos severelyimpairedmicrovascularreactivityindiabeticpatientswithanacutecoronarysyndrome
AT jorneskoggun severelyimpairedmicrovascularreactivityindiabeticpatientswithanacutecoronarysyndrome
AT bengtssonmattias severelyimpairedmicrovascularreactivityindiabeticpatientswithanacutecoronarysyndrome
AT kahanthomas severelyimpairedmicrovascularreactivityindiabeticpatientswithanacutecoronarysyndrome
AT kalanimajid severelyimpairedmicrovascularreactivityindiabeticpatientswithanacutecoronarysyndrome